Open AccessPB2149: ZANUBRUTINIB IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB VERSUS R‐MINICHOP IN UNFIT OR FRAIL PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA AGED OVER OR EQUAL TO 70 YEARS
Author(s) -
Xu P.,
Shi Z.,
Wang L.,
Cheng S.,
Zhao W.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851424.52784.bc
Subject(s) - medicine , rituximab , lenalidomide , diffuse large b cell lymphoma , regimen , clinical endpoint , performance status , oncology , randomized controlled trial , surgery , lymphoma , chemotherapy , multiple myeloma